TalkMed Group Past Earnings Performance
Past criteria checks 2/6
TalkMed Group's earnings have been declining at an average annual rate of -1%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 3.7% per year. TalkMed Group's return on equity is 33.6%, and it has net margins of 35.8%.
Key information
-1.0%
Earnings growth rate
-1.2%
EPS growth rate
Healthcare Industry Growth | 9.7% |
Revenue growth rate | 3.7% |
Return on equity | 33.6% |
Net Margin | 35.8% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How TalkMed Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 79 | 28 | 1 | 0 |
31 Mar 24 | 81 | 30 | 1 | 0 |
31 Dec 23 | 84 | 32 | 1 | 0 |
30 Sep 23 | 83 | 31 | 1 | 0 |
30 Jun 23 | 82 | 31 | 1 | 0 |
31 Mar 23 | 79 | 31 | 1 | 0 |
31 Dec 22 | 77 | 31 | 1 | 0 |
30 Sep 22 | 70 | 28 | 1 | 0 |
30 Jun 22 | 64 | 26 | 1 | 0 |
31 Mar 22 | 63 | 26 | 1 | 0 |
31 Dec 21 | 61 | 25 | 1 | 0 |
30 Sep 21 | 62 | 25 | 1 | 0 |
30 Jun 21 | 60 | 23 | 1 | 0 |
31 Mar 21 | 61 | 23 | 1 | 0 |
31 Dec 20 | 62 | 23 | 2 | 0 |
30 Sep 20 | 67 | 27 | 2 | 0 |
30 Jun 20 | 71 | 31 | 2 | 0 |
31 Mar 20 | 74 | 34 | 1 | 0 |
31 Dec 19 | 76 | 36 | 0 | 0 |
30 Sep 19 | 73 | 34 | 1 | 0 |
30 Jun 19 | 71 | 33 | 1 | 0 |
31 Mar 19 | 66 | 31 | 2 | 0 |
31 Dec 18 | 61 | 29 | 2 | 0 |
30 Sep 18 | 58 | 28 | 3 | 0 |
30 Jun 18 | 55 | 27 | 2 | 0 |
31 Mar 18 | 57 | 29 | 2 | 0 |
31 Dec 17 | 61 | 32 | 2 | 0 |
30 Sep 17 | 65 | 34 | 2 | 0 |
30 Jun 17 | 68 | 35 | 2 | 0 |
31 Mar 17 | 69 | 37 | 2 | 0 |
31 Dec 16 | 69 | 37 | 2 | 0 |
30 Sep 16 | 68 | 37 | 1 | 0 |
30 Jun 16 | 67 | 36 | 1 | 0 |
31 Mar 16 | 66 | 36 | 1 | 0 |
31 Dec 15 | 66 | 37 | 1 | 0 |
30 Sep 15 | 65 | 38 | 1 | 0 |
30 Jun 15 | 65 | 40 | 1 | 0 |
31 Mar 15 | 65 | 40 | 1 | 0 |
31 Dec 14 | 63 | 39 | 1 | 0 |
30 Sep 14 | 61 | 32 | 1 | 0 |
30 Jun 14 | 59 | 31 | 1 | 0 |
31 Mar 14 | 58 | 30 | 0 | 0 |
31 Dec 13 | 56 | 28 | 0 | 0 |
Quality Earnings: 5G3 has high quality earnings.
Growing Profit Margin: 5G3's current net profit margins (35.8%) are lower than last year (37.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 5G3's earnings have declined by 1% per year over the past 5 years.
Accelerating Growth: 5G3's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 5G3 had negative earnings growth (-8.4%) over the past year, making it difficult to compare to the Healthcare industry average (-35.5%).
Return on Equity
High ROE: 5G3's Return on Equity (33.6%) is considered high.